Startups
Health + Tech, Investing, Startups
Volumetric to be acquired by 3D Systems ($DDD) in a deal worth up to $400M
Congratulations to the Volumetric team on their acquisition by 3D Systems!
Continue Reading >
Startups
Juno Diagnostics Investment
Juno Diagnostics, a San Diego based genetic diagnostics company in the Bioverge portfolio, just raised a $25 million Series A round led by Perceptive Xontogeny Venture Fund in May 2021.
Continue Reading >
Health + Tech, Investing, Startups
✨ New Investment Opportunity: Transforming Epilepsy Care 🙇
Invest in Eysz to accelerate personalized treatments with improved patient outcomes for 70M+ epilepsy patients worldwide.
Continue Reading >
Health + Tech, Investing, Startups
Congratulations, Echo!
Congratulations to our portfolio company Echo on their acquisition by CELLINK!
Continue Reading >
Health + Tech, Startups
Repair Biotechnologies is Tackling Longevity
The desire to prolong life and youthful vigor has existed for centuries without uniformly tangible results. Repair Biotechnologies offers to transform this desire into a reality.
Continue Reading >
Health + Tech, Startups
Advancing Treatments for ALS and Neurodegenerative Diseases
EnClear Therapies is developing device-based systems to reduce or stop the progression of neurodegenerative diseases by eliminating the toxic proteins that provoke these conditions.
Continue Reading >
Health + Tech, Media, Startups
Ancilia Presentation and Q&A with CEO Alexandra Sakatos
Ancilia is a computational bio-platform company that engineers phage-resistant bacterial therapeutics utilizing CRISPR/Cas to treat microbiome-linked diseases including inflammatory bowel disease (IBD) and immunotherapy-associated colitis.
Continue Reading >
Media, Startups
Octagon Therapeutics Presentation and Q&A with CEO Isaac Stoner
Octagon Therapeutics is developing targeted small molecules with selectivity towards autoimmune diseases
Continue Reading >
Media, Startups
IVIVA Medical: Next Generation Human Tissue
IVIVA Medical was founded with the goal of developing autologous tissue constructs as a solution to end-state renal disease (ESRD). The IVIVA team is leveraging emerging complementary technologies in tissue engineering, 3D additive manufacturing, and stem cell biology in order to realize the potential of regenerative medicine to end donor organ shortage.
Continue Reading >
Media, Startups
HepaTx is developing revolutionary stem cell-based therapies for liver disease
HepaTx is developing revolutionary stem cell-based therapies for liver disease
Continue Reading >